Race/ethnic disparities in reproductive age: an examination of ovarian reserve estimates across four race/ethnic groups of healthy, regularly cycling.

Slides:



Advertisements
Similar presentations
Effect of detorsion alone and in combination with enoxaparin therapy on ovarian reserve and serum antimüllerian hormone levels in a rat ovarian torsion.
Advertisements

Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States  David B. Seifer, M.D., Valerie.
Age at menarche: a predictor of diminished ovarian function?
Daily physical activity and hot flashes in the Study of Women's Health Across the Nation (SWAN) Flashes Study  Carolyn Gibson, M.P.H., M.S., Karen Matthews,
Karl R. Hansen, M. D. , Ph. D. , George M. Hodnett, M. D
The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition  Lorraine Dennerstein,
Infertility evaluation and treatment among women in the United States
Fernando Zegers-Hochschild, M.D.  Fertility and Sterility 
Michael M. Alper, M.D.  Fertility and Sterility 
Mike Ripley, M. D. , F. R. C. S. C. , Andrea Lanes, M. Sc
Janet Kwee, M. D. , Roel Schats, M. D. , Ph. D. , Joseph McDonnell, M
Dennis J. Hand, Ph. D. , Vanessa L. Short, Ph. D. , M. P. H. , Diane J
A model for predicting age at menopause in white women
Antimüllerian hormone: correlation with age and androgenic and metabolic factors in women from birth to postmenopause  Linlin Cui, M.D., Ph.D., Yingying.
Ethnicity as a determinant of ovarian reserve: differences in ovarian aging between Spanish and Indian women  Carlos Iglesias, M.D., Manish Banker, M.D.,
Contribution of the rate of change of antimüllerian hormone in estimating time to menopause for late reproductive-age women  Ellen W. Freeman, Ph.D.,
The prevalence of eating disorders in infertile women
Antimüllerian hormone as a predictor of live birth following assisted reproduction: an analysis of 85,062 fresh and thawed cycles from the Society for.
Serum antimüllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids  Isabelle.
Temporal trends in clomiphene citrate use: a population-based study
Antimüllerian hormone levels and antral follicle counts are not reduced compared with community controls in patients with rigorously defined unexplained.
Changes in affect and state anxiety across an in vitro fertilization/intracytoplasmic sperm injection cycle  Neha N. Mahajan, Ph.D., Deborah A. Turnbull,
Follicle-stimulating hormone administered at the time of human chorionic gonadotropin trigger improves oocyte developmental competence in in vitro fertilization.
The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count  Simone L. Broer, B.Sc., Ben Willem J.
Genotypically determined ancestry across an infertile population: ovarian reserve and response parameters are not influenced by continental origin  Meir.
Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers  Andrea.
Hakan Cakmak, M. D. , Audra Katz, R. N. , Marcelle I. Cedars, M. D
Rebecca A. Feldman, M. D. , Kathleen O'Neill, M. D. , Samantha F
How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization  Robert L. Klitzman, M.D.  Fertility.
A comparison of blood spot vs
Antral follicle count: absence of significant midlife decline
Elevated body mass index is associated with lower serum anti-mullerian hormone levels in infertile women with diminished ovarian reserve but not with.
Triploidy formation after intracytoplasmic sperm injection may be a surrogate marker for implantation  Mitchell P. Rosen, M.D., Shehua Shen, M.D., Anthony.
Ellen W. Freeman, Ph. D. , Clarisa R. Gracia, M. D. , Mary D
Oocyte cryopreservation
Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine.
Mitchell P. Rosen, M. D. , Shehua Shen, M. D. , Charles E
Do anti-mullerian hormone levels predict ovarian reserve in SLE patients presenting for hematopoietic stem cell transplant?  H. Browne, A. Armstrong,
Deleterious effect of tobacco on IVF outcome and ovarian reserve as reflected by serum anti mullerian hormone (AMH)  P. Barriere, T. Freour, D. Masson,
Clinical course of depression symptoms and predictors of enduring depression risk in women with polycystic ovary syndrome: Results of a longitudinal study 
Mieke Carine Wim Eeckhaut, Ph.D.  Fertility and Sterility 
Looking back: egg donors' retrospective evaluations of their motivations, expectations, and experiences during their first donation cycle  Nancy J. Kenney,
Links between age at menarche, antral follicle count, and body mass index in African American and European American women  Sonya M. Schuh, Ph.D., Julia.
Improvement of hyperandrogenism and hyperinsulinemia during pregnancy in women with polycystic ovary syndrome: possible effect in the ovarian follicular.
Association between prior appendectomy and/or tonsillectomy in women and subsequent pregnancy rate: a cohort study  Li Wei, Ph.D., Thomas MacDonald, M.D.,
Impact of pituitary suppression on antral follicle count and oocyte recovery after ovarian stimulation  Nam D. Tran, M.D., Ph.D., Lusine Aghajanova, M.D.,
Tomer Singer, M. D. , David H. Barad, M. D. , M. S
Management of tubal ectopic pregnancy: methotrexate and salpingostomy are preferred to preserve fertility  Stephanie Beall, M.D., Ph.D., Alan H. DeCherney,
Antimüllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis  Reshef Tal,
Mitchell P. Rosen, M. D. , Erica Johnstone, M. D. , Charles E
Assisted reproductive technology practice patterns and the impact of embryo transfer guidelines in the United States  Judy E. Stern, Ph.D., Marcelle I.
Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles  Karin.
Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D. 
Lower apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in vitro.
Antimüllerian hormone and antral follicle count are lower in female cancer survivors and healthy women taking hormonal contraception  Lauren N.C. Johnson,
Simple tools for assessment of ovarian reserve (OR): individual ovarian dimensions are reliable predictors of OR  Stacea Bowen, M.D., John Norian, M.D.,
Clinical uses of anti-Müllerian hormone assays: pitfalls and promises
Association of adolescent obesity and lifetime nulliparity—The Study of Women's Health Across the Nation (SWAN)  Alex J. Polotsky, M.D., M.S., Susan M.
Cameron Gilbert, M. Sc. , Maria Valois, M. D. , FRCPC, Ph. D
Fertility and Sterility: an evaluation
Association of endometriosis with body size and figure
Current evaluation of amenorrhea
Aline Ketefian, M. D. , Jianfang Hu, Ph. D. , Alfred A. Bartolucci, Ph
Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function  David H. Barad, M.D., M.S., Andrea Weghofer,
Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories  Melissa C. Yih, M.D.,
Cem Fiçicioǧlu, M. D. , Tayfun Kutlu, M. D. , Elif Baglam, M. D
Soluble HLA-G in the peritoneal fluid of women with endometriosis
A novel “delayed start” protocol with gonadotropin-releasing hormone antagonist improves outcomes in poor responders  Hakan Cakmak, M.D., Nam D. Tran,
A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three- dimensional ultrasound determinants of ovarian reserve in the prediction.
Comparisons of inhibin B versus antimüllerian hormone in poor ovarian responders undergoing in vitro fertilization  Rongrong Tan, M.M.Sc., Danhua Pu,
Presentation transcript:

Race/ethnic disparities in reproductive age: an examination of ovarian reserve estimates across four race/ethnic groups of healthy, regularly cycling women  Maria E. Bleil, Ph.D., Steven E. Gregorich, Ph.D., Nancy E. Adler, Ph.D., Barbara Sternfeld, Ph.D., Mitchell P. Rosen, M.D., Marcelle I. Cedars, M.D.  Fertility and Sterility  Volume 101, Issue 1, Pages 199-207 (January 2014) DOI: 10.1016/j.fertnstert.2013.09.015 Copyright © 2014 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Predicted geometric mean antimüllerian hormone (AMH) values in each race/ethnic group calculated across the sample age range (holding BMI constant at the sample mean) among 947 premenopausal women. Fertility and Sterility 2014 101, 199-207DOI: (10.1016/j.fertnstert.2013.09.015) Copyright © 2014 American Society for Reproductive Medicine Terms and Conditions